Sagimet Biosciences Stock Gains After Pricing $115M Equity Offering

Key Facts

1Sagimet Biosciences priced a securities offering valued at $115 million.

2The company's stock rose following the announcement of the offering's pricing details.

Sagimet Biosciences priced a securities offering valued at $115 million. Seeking Alpha reported that the company's stock rose following the announcement of the offering's pricing details.

SGMT closed at $9.33 on September 29, 2026, with the stock reaching a day high of $9.92 and a low of $9.25 during that session. This price movement follows the company's successful capital raise through the common stock offering.